Literature DB >> 15528755

Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin.

Gyöngyi Lukács1, Tamás Papp, Ildikó Nyilasi, Erzsébet Nagy, Csaba Vágvölgyi.   

Abstract

The opportunistic pathogens Rhizomucor pusillus and Rhizomucor miehei may be agents of frequently fatal mycotic diseases. In the present study, the susceptibilities of 27 clinical and environmental isolates of R. miehei and R. pusillus to lovastatin under different culturing conditions were investigated. Most of the R. miehei strains grew at lovastatin concentrations as high as 64 to 128 microg/ml. In contrast, the inhibitory effect of lovastatin on all of the R. pusillus strains was evident at lovastatin concentrations as low as 1 to 2 microg/ml. A simple and reliable method for species-level differentiation, based on the significantly higher sensitivity of R. pusillus to lovastatin than that of R. miehei, was elaborated. According this, on malt extract agar containing 6 mug of lovastatin/ml, R. pusillus is not able to produce colonies, while R. miehei will form compact colonies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528755      PMCID: PMC525180          DOI: 10.1128/JCM.42.11.5400-5402.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

Review 1.  Mucormycoses.

Authors:  J Eucker; O Sezer; B Graf; K Possinger
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

Review 2.  Allergic Rhizomucor sinusitis.

Authors:  M F Goldstein; D J Dvorin; E H Dunsky; R W Lesser; P J Heuman; J H Loose
Journal:  J Allergy Clin Immunol       Date:  1992-09       Impact factor: 10.793

3.  Cellulitis caused by Rhizomucor pusillus in a diabetic patient receiving continuous insulin infusion pump therapy.

Authors:  C L Wickline; T G Cornitius; T Butler
Journal:  South Med J       Date:  1989-11       Impact factor: 0.954

4.  Zygospores: the last word in identification of rare or atypical zygomycetes isolated from clinical specimens.

Authors:  I Weitzman; S Whittier; J C McKitrick; P Della-Latta
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

5.  Intraspecific variation in two species of Rhizomucor assessed by random amplified polymorphic DNA analysis.

Authors:  M Vastag; T Papp; Z Kasza; C Vágvölgyi
Journal:  J Basic Microbiol       Date:  2000       Impact factor: 2.281

Review 6.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia.

Authors:  M Björkholm; G Runarsson; F Celsing; M Kalin; B Petrini; P Engervall
Journal:  Scand J Infect Dis       Date:  2001

Review 8.  Infectious emergencies in patients with diabetes mellitus.

Authors:  K O Smitherman; J E Peacock
Journal:  Med Clin North Am       Date:  1995-01       Impact factor: 5.456

9.  Lovastatin triggers an apoptosis-like cell death process in the fungus Mucor racemosus.

Authors:  L V Roze; J E Linz
Journal:  Fungal Genet Biol       Date:  1998-11       Impact factor: 3.495

Review 10.  Infection due to Rhizomucor pusillus: report of four cases in patients with leukemia and review.

Authors:  G St-Germain; A Robert; M Ishak; C Tremblay; S Claveau
Journal:  Clin Infect Dis       Date:  1993-05       Impact factor: 9.079

View more
  8 in total

1.  Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.

Authors:  Georgios Chamilos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 2.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia.

Authors:  Peter C Iwen; Alison G Freifeld; Lynne Sigler; Stefano R Tarantolo
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Identification of fungal pathogens in a patient with acute myelogenic leukemia using a pathogen detection array technology.

Authors:  Sagarika Banerjee; Kristen N Peck; Michael D Feldman; Mindy G Schuster; James C Alwine; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

Review 5.  Invasive mold infections in solid organ transplant recipients.

Authors:  Yoann Crabol; Olivier Lortholary
Journal:  Scientifica (Cairo)       Date:  2014-11-23

Review 6.  Risk assessment of fungal materials.

Authors:  Jeroen G van den Brandhof; Han A B Wösten
Journal:  Fungal Biol Biotechnol       Date:  2022-02-24

7.  Identification of Filamentous Fungi by MALDI-TOF Mass Spectrometry: Evaluation of Three Different Sample Preparation Methods and Validation of an In-House Species Cutoff.

Authors:  Claudia Honsig; Brigitte Selitsch; Marlene Hollenstein; Matthias G Vossen; Kathrin Spettel; Birgit Willinger
Journal:  J Fungi (Basel)       Date:  2022-04-10

8.  Antifungal activity of Thymus vulgaris L. essential oil and its constituent phytochemicals against Rhizopus oryzae: interaction with ergosterol.

Authors:  Kelly Samara de Lira Mota; Fillipe de Oliveira Pereira; Wylly Araújo de Oliveira; Igara Oliveira Lima; Edeltrudes de Oliveira Lima
Journal:  Molecules       Date:  2012-12-05       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.